68Ga-FAPI PET in Evaluation of the Patient With Known or Suspected Lung Cancer: Comparison With Standard 18F-FDG PET
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This is a prospective, single-center, single arm, open label study to evaluate the performance of 68Ga-FAPI-46 for the diagnosis of primary and metastatic lesions of lung cancer with comparison to 18F-FDG PET.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Healthy Volunteers: f
View:
• Age \> 20 years
• Informed consent obtained from patients and families
• Patients with histology confirmed lung cancer or patients with GGO on chest CT planned to have biopsy or surgery
• Patients scheduled to undergo FDG-PET examination
• Performance status: 0, 1, 2, 3
Locations
Other Locations
Taiwan
Department of Nuclear Medicine, Chang Gung Memorial Hospital
RECRUITING
Taoyuan District
Contact Information
Primary
Kung-Chu Ho, MD
b8301068@gmail.com
+886975365783
Time Frame
Start Date: 2023-04-01
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 103
Treatments
Experimental: 68Ga-FAPI-46 PET Scan
A single-center prospective interventional single-arm clinical trial. All patients will undergo whole-body 68Ga-FAPI-46 PET scan within two weeks before or after 18F-FDG-PET. Injected activity of 68Ga-FAPI-46 is limited to 100-250 MBq per examination.
Related Therapeutic Areas
Sponsors
Leads: Chang Gung Memorial Hospital